Wingen F, Schmähl D
Arzneimittelforschung. 1985;35(10):1565-71.
The distribution of 14C-APD and 99mTc-APD (APD = 3-amino-1-hydroxypropane-1,1-diphosphonic acid) in untreated rats and in rats bearing intratibially transplanted osteosarcomas was investigated autoradiographically and scintigraphically. Also investigated was the effect of high doses of APD on survival time and tumor growth of osteosarcoma-bearing rats. Intravenous administration of APD resulted in high rates of APD accumulation in bones, tumor tissue and pulmonary metastases as well as in dose-related accumulation in the liver. No significant increase in the median survival time of tumor-bearing animals was achieved at the two dosage schemes tested, i.e. 2 X 23.5 mg/kg and 10 X 11.75 mg/kg APD. The growth of primary tumors was slightly increased by administration of APD. The chemosensitivity of the transplantable osteosarcoma model was demonstrated by comparison with dacarbazine-treated control animals.
采用放射自显影和闪烁扫描法研究了14C-APD和99mTc-APD(APD = 3-氨基-1-羟基丙烷-1,1-二膦酸)在未治疗大鼠和胫骨内移植骨肉瘤大鼠体内的分布。同时研究了高剂量APD对荷骨肉瘤大鼠生存时间和肿瘤生长的影响。静脉注射APD导致其在骨骼、肿瘤组织和肺转移灶中大量蓄积,且在肝脏中的蓄积与剂量相关。在测试的两种给药方案下,即2×23.5 mg/kg和10×11.75 mg/kg APD,荷瘤动物的中位生存时间均未显著增加。给予APD后,原发性肿瘤的生长略有增加。通过与达卡巴嗪治疗的对照动物比较,证明了可移植骨肉瘤模型的化学敏感性。